Skip to main content

For Healthcare Professionals

Logout

Boehringer Ingelheim

Boehringer Ingelheim

Boehringer Ingelheim

Therapeutic Area
Therapeutic Area

At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. Our Focus articulates who we are and what we strive for, how we work and what we want to achieve.

Section Overview

Therapeutic Area

Section Overview

Metabolic

Cardiovascular

Respiratory

Specialty

Oncology
Resources
Contact
Logout

Boehringer Ingelheim

Leave this field blank

COPD
About ILD
Guideline Recommendations
Optimising COPD therapy
Tovito
Topic On Pod
9th RRX

Respiratory

Boehringer Ingelheim has over 90 years of heritage in managing respiratory disease. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life

Respiratory

Hightlight Symposium

23/12/2024 | Author: Boehringer Ingelheim

Document ID: PC-TH-105134

RELATED CONTENT

Thumbnail_EP2

11:17

"On Air" The series - EP.2 20th year Recap: What's going on with COPD care?

Watch now Opens in new tab

What's new in COPD treatment guideline today

12:11

"On Air" The series - EP.1 Tuning: What's new in COPD treatment guideline today?

Watch now Opens in new tab

Home
Respiratory
Spiolto
COPD
Learn About Spiolto at the COPD Symposium

Sitemap

Therapeutic Area

Resources
- Videos

BI logo

Privacy
Terms of use
Sitemap
Contact

This website is intended for healthcare professionals in Thailand. The contents of this website are for information purposes only and are not intended to substitute for advice, treatment or recommendations of a healthcare professional. For your health concerns and other questions about symptoms, treatment or medication, consult a healthcare professional.

Copyright © 2024 Boehringer Ingelheim (Thai) Ltd.
All rights reserved. Use of this Site is subject to the Terms of Use and Privacy Statement.